30DEC

Libyan International Conference for Health Sciences

The First Libyan International Conference for Health Sciences (2024): Open University, Tripoli, Libya
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
https://app.periodikos.com.br/journal/medjpps/article/doi/10.5281/zenodo.10396239

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences

Short communication

Evaluation of diabetes mellitus type 2 effects on kidney function

Basem M. Rajab, Anwar A. Abodhier, Esra N. Zreiba, Shaima Y. Abosbea

Downloads: 0
Views: 231

Abstract

Type 2 Diabetes mellitus contributes to the development or progression of many chronic and age-related pathological processes. One of the major risk factors for morbidity and mortality among patients with diabetes is renal and vascular disease as well as heart disease. Type 2 diabetes mellitus was associated with a significantly increased age of kidney disease with higher urea and creatinine levels. 76 Libyan subjects participated in the study. The subjects were divided into three categories. One group hosts a diabetes case (n=40) while the other group serves as a control (n=12) and the other group has no type 2 diabetes mellitus but urea and creatinine levels are elevated (n=36). After oral informed consent of the study participants, 5 ml of venous blood was drawn under sterile conditions for whole blood analysis. Fasting blood sugar was analyzed. Urea and creatinine levels were compared between diabetic and non-diabetic patients. However, a statistical analysis was performed using IBM SPSS version 26 where the correlation between parameters was analyzed by an independent samples t-test. In this study, patients with type 2 diabetes mellitus caused a significant increase in urea and creatinine compared to the control group. The study indicated that type 2 diabetes mellitus increases the damage to kidney function.

Keywords

Diabetes mellitus, diabetic kidney disease, fasting blood sugar, hemoglobin, Libya

References

  1. Galtier F (2010) Definition, epidemiology, risk factors. Diabetes and Metabolism. 36 (6, 2): 628-651. doi: 10.1016/ j.diabet.2010.11.014
  2. Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A (2019) The risk of mortality among people with type 2 diabetes in Latin America: a systematic review and meta-analysis of population-based cohort studies. Diabetes/Metabolism Research and Reviews. 35 (4): e3139. doi: 10.1002/dmrr.3139
  3. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH (2016) Clinical manifestations of kidney disease among US adults with diabetes. 1988-2014. JAMA. 316 (6): 602-610. doi: 10.1001/jama.2016. 10924
  4. Bailey RA, Wang Y, Zhu V, Rupnow MF (2014) Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on kidney disease: Improving Global Outcomes (KDIGO) staging. BMC Research Notes. 7: 415. doi: 10.1186/1756-0500-7-415
  5. Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KA, Zoungas S, Rossing P, Groop P-H, Cooper ME (2015) Diabetic kidney disease. Nature Reviews, Disease Primers. 1: 15018. doi: 10.1038/nrdp.2015.18
  6. Bjerg L, Hulman A, Carstensen B, Charles M, Jorgensen ME, Witte DR (2018) Development of microvascular complications and effect of concurrent risk factors in type 1 diabetes: a multistate model from an observational clinical cohort study. Diabetes Care. 41 (11): 2297-2305. doi: 10.2337/dc18-0679
  7. Valencia WM, Florez H (2017) How to prevent the microvascular complications of type 2 diabetes beyond glucose control. The British Medical Journal. 356: i6505. doi: 10.1136/bmj.i6505
  8. Cameron JS (2006) The discovery of diabetic nephropathy: from small print to centre stage. Journal of Nephrology. 19 (Suppl 10): S75-S87. PMID: 16874718.
  9. Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clinical Journal of the American Society of Nephrology. 12 (12): 2032-2045. doi: 10.2215/CJN.11491116
  10. Ritz E, Rychlík I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. American Journal of Kidney Disease. 34 (5): 795-808. doi: 10.1016/S02726386(99)700351
  11. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L (2014) Changes in diabetes- related complications in the United States, 1990-2010. The New England Journal of Medicine. 370 (16): 1514-1523. doi: 10.1056/NEJMoa1310799
  12. Hussain S, Chowdhury TA (2019) The impact of comorbidities on the pharmacological management of type 2 diabetes mellitus. Drugs. 79 (3): 231-242. doi: 10.1007/s40265-019-1061-4
  13. Kempegowda P, Chandan JS, Abdulrahman S, Chauhan A, Saeed MA (2019) Managing hypertension in people of African origin with diabetes: Evaluation of adherence to NICE Guidelines. Primary Care Diabetes. 13 (3): 266-271. doi: 10.1016/j.pcd.2018.12.007
  14. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK (2016) Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 11: 95-104. doi: 10.4137/BMI.S38440
  15. Corbett JV, Banks A (2018) Laboratory tests and diagnostic procedures with nursing diagnoses. Pearson, 9th ed. ISBN: 978-0134749389.
  16. Pagana KD, Pagana TJ (2015) Mosby's manual of diagnostic and laboratory test reference. 12th ed. St. Louis, Elsevier Mosby Inc. ISBN: 978-0-323-22576-2.
  17. Qi C, Mao X, Zhang Z, Wu H (2017) Classification and differential diagnosis of diabetic nephropathy. Journal of Diabetes Research. 2017: 8637138. doi: 10.1155/2017/8637138
  18. Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J, Mundet-Tuduri X, Barrot-De la Puente J, Coll-de Tuero G, Red GDPS Study Group (2013) Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrology. 14, 46. 14: 46. doi: 10.1186/1471-2369-14-46
  19. Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB (2012) Renal dysfunction in the presence of normoalbuminuric in type 2 diabetes: results from the DEMAND study. Cardiorenal Medicine. 2 (1): 1-10. doi: 10.1159/000333249
  20. Aldler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP (2003) Development and progression of nephropathy in type 2 diabetes (the United Kingdom prospective diabetes study). Kidney International. 63 (1): 225-232. doi: 10.1046/j.1523-1755.2003.00712.x
  21. Tufan F, Yıldız A, Dogan I, Yıldız D, Sevinir S (2015) Urea to creatinine ratio: a forgotten marker of poor nutritional state in patients undergoing hemodialysis treatment. Aging Male. 18 (1): 49-53. doi: 10.3109/13685538. 2014. 908281
  22. Ashavaid TF, Todur SP, Dherai AJ (2005) Establishment of reference intervals in Indians population. Indian Journal of Clinical Biochemistry. 20: 110-118. doi: 10.3109/13685538.2014.908281
  23. Elmiladi SA, Elgdhafi EO (2023) Prevalence of cardiovascular risk factors in Libyan patients with type 2 diabetes mellitus. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 3 (2): 27-35. doi: 10.5281/zenodo. 7877416
  24. Elmiladi SA, Elmurabth S (2021) Therapy and characteristics of hypoglycemia in admitted diabetic patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 1 (4): 77-83. doi: 10.528/zenodo.5806156

Submitted date:
11/14/2023

Reviewed date:
12/06/2023

Accepted date:
12/12/2023

Publication date:
07/20/2024

669c0f14a9539522e82bba42 medjpps Articles
Links & Downloads

Mediterr J Pharm Pharm Sci

Share this page
Page Sections